PE20030580A1 - Composiciones farmaceuticas de glibenclamida y metformina, en capas separadas - Google Patents
Composiciones farmaceuticas de glibenclamida y metformina, en capas separadasInfo
- Publication number
- PE20030580A1 PE20030580A1 PE2002001140A PE2002001140A PE20030580A1 PE 20030580 A1 PE20030580 A1 PE 20030580A1 PE 2002001140 A PE2002001140 A PE 2002001140A PE 2002001140 A PE2002001140 A PE 2002001140A PE 20030580 A1 PE20030580 A1 PE 20030580A1
- Authority
- PE
- Peru
- Prior art keywords
- metformin
- tablets
- layer
- glybenclamide
- compressed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A FORMULACIONES FARMACEUTICAS SUMINISTRABLES POR VIA ORAL QUE COMPRENDEN COMO PRINCIPIO ACTIVO EN CADA COMPRIMIDO: 1)1 mg A 20 mg DE GLIBENCLAMIDA; Y 2)200 mg A 1000 mg DE METFORMINA O SUS SALES FARMACEUTICAMENTE ACEPTABLES. DONDE (1) Y (2) ESTAN COMPRIMIDOS EN CAPAS SEPARADAS ENTRE ELLAS Y LOS COMPRIMIDOS SON SELECCIONADOS DE: i)COMPRIMIDOS POLICAPA; Y, ii)COMPRIMIDOS RECUBIERTOS, ENCONTRANDOSE (1) SIEMPRE EN POR LO MENOS UNA CAPA EXTERIOR DE (i) O EN LA COBERTURA DE (ii). SIENDO (i) SELECCIONADO DE: COMPRIMIDOS BICAPA EN LOS CUALES (1) ES COMPRIMIDA EN UNA CAPA RELATIVAMENTE DELGADA SOBRE UN COMPRIMIDO DE METFORMINA; Y COMPRIMIDOS TRICAPA EN LOS CUALES (1) ES COMPRIMIDA ENTRE DOS CAPAS UBICADAS UNA ARRIBA Y LA OTRA DEBAJO DE UNA CAPA CENTRAL DE METFORMINA; Y (ii) SELECCIONADO DE: COMPRIMIDOS DE METFORMINA RECUBIERTOS UNIFORMEMENTE POR UNA CAPA DELGADA QUE CONTIENE (1) Y COMPRIMIDOS DE METFORMINA BARNIZADOS EN EL EXTERIOR CON UNA SOLUCION DE GLIBENCLAMIDA QUE SE ESTRATIFICA SOBRE LOS MISMOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001FI000230A ITFI20010230A1 (it) | 2001-11-29 | 2001-11-29 | Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030580A1 true PE20030580A1 (es) | 2003-09-05 |
Family
ID=11442301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002001140A PE20030580A1 (es) | 2001-11-29 | 2002-11-26 | Composiciones farmaceuticas de glibenclamida y metformina, en capas separadas |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US20050053661A1 (es) |
| EP (1) | EP1458364B1 (es) |
| JP (1) | JP4474162B2 (es) |
| KR (1) | KR20040079898A (es) |
| CN (1) | CN1596103B (es) |
| AR (1) | AR037407A1 (es) |
| AT (1) | ATE387190T1 (es) |
| AU (1) | AU2002358061B2 (es) |
| BR (1) | BR0214403A (es) |
| CA (1) | CA2466677A1 (es) |
| CO (1) | CO5590906A2 (es) |
| CY (1) | CY1107966T1 (es) |
| DE (1) | DE60225331T2 (es) |
| DK (1) | DK1458364T3 (es) |
| EA (1) | EA006766B1 (es) |
| EG (1) | EG24124A (es) |
| ES (1) | ES2302862T3 (es) |
| HK (1) | HK1069974A1 (es) |
| HN (1) | HN2002000341A (es) |
| HR (1) | HRP20040501A2 (es) |
| HU (1) | HUP0402154A3 (es) |
| IL (1) | IL162143A0 (es) |
| IT (1) | ITFI20010230A1 (es) |
| MA (1) | MA27087A1 (es) |
| MX (1) | MXPA04004974A (es) |
| MY (1) | MY141243A (es) |
| NO (1) | NO20042713L (es) |
| NZ (1) | NZ533779A (es) |
| PA (1) | PA8559801A1 (es) |
| PE (1) | PE20030580A1 (es) |
| PL (1) | PL206016B1 (es) |
| PT (1) | PT1458364E (es) |
| RS (1) | RS50937B (es) |
| SI (1) | SI1458364T1 (es) |
| SV (1) | SV2004001415A (es) |
| TN (1) | TNSN04095A1 (es) |
| UA (1) | UA81615C2 (es) |
| UY (1) | UY27549A1 (es) |
| WO (1) | WO2003045355A1 (es) |
| ZA (1) | ZA200404880B (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7964216B2 (en) * | 2001-01-12 | 2011-06-21 | Sun Pharma Advanced Research Company Limited | Spaced drug delivery system |
| WO2003105809A1 (en) | 2002-06-17 | 2003-12-24 | Themis Laboratories Private Limited | Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them |
| US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| PT2316456T (pt) | 2003-04-29 | 2017-09-05 | Orexigen Therapeutics Inc | Composições para afetar a perda de peso compreendendo naltrexona e bupropion |
| UY29445A1 (es) * | 2005-03-30 | 2006-10-02 | Generex Pharm Inc | Composiciones para la transmisión transmucosa oral de la metformina |
| TWI471145B (zh) * | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| CN101588795A (zh) * | 2006-11-09 | 2009-11-25 | 奥雷西根治疗公司 | 包含中间快速溶解层的分层药物制剂 |
| ITMI20062254A1 (it) * | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
| US20110144145A1 (en) | 2008-05-30 | 2011-06-16 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| CA2638240C (en) | 2008-08-29 | 2010-02-02 | Alexander Macgregor | Method of treating dysglycemia and glucose excursions |
| AU2011203867B2 (en) | 2010-01-11 | 2015-12-03 | Nalpropion Pharmaceuticals Llc | Methods of providing weight loss therapy in patients with major depression |
| RU2483717C2 (ru) * | 2010-11-22 | 2013-06-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения диабета (варианты) |
| US11974971B2 (en) | 2011-01-07 | 2024-05-07 | Anji Pharmaceuticals Inc. | Compositions and methods for treating metabolic disorders |
| WO2012094636A2 (en) | 2011-01-07 | 2012-07-12 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
| US9480663B2 (en) | 2011-01-07 | 2016-11-01 | Elcelyx Therapeutics, Inc. | Biguanide compositions and methods of treating metabolic disorders |
| US11759441B2 (en) | 2011-01-07 | 2023-09-19 | Anji Pharmaceuticals Inc. | Biguanide compositions and methods of treating metabolic disorders |
| US9211263B2 (en) | 2012-01-06 | 2015-12-15 | Elcelyx Therapeutics, Inc. | Compositions and methods of treating metabolic disorders |
| US9572784B2 (en) | 2011-01-07 | 2017-02-21 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| US8796338B2 (en) | 2011-01-07 | 2014-08-05 | Elcelyx Therapeutics, Inc | Biguanide compositions and methods of treating metabolic disorders |
| ES2832773T3 (es) | 2012-01-06 | 2021-06-11 | Anji Pharma Us Llc | Composiciones de biguanida y métodos de tratamiento de trastornos metabólicos |
| AU2013207329B2 (en) | 2012-01-06 | 2017-10-26 | Anji Pharmaceuticals Inc. | Compositions and methods for treating metabolic disorders |
| EP2858640B1 (en) | 2012-06-06 | 2020-03-25 | Nalpropion Pharmaceuticals LLC | Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
| KR20170083071A (ko) | 2014-11-11 | 2017-07-17 | 시오노기 앤드 컴파니, 리미티드 | 광에 대해서 불안정한 약물을 함유하는 다층 정제 |
| KR101750690B1 (ko) * | 2015-10-28 | 2017-06-27 | 주식회사 종근당 | 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물 |
| CN105596339A (zh) * | 2015-12-23 | 2016-05-25 | 青岛海之源智能技术有限公司 | 一种二甲双胍阿昔莫司复方组合物及制备方法 |
| CN110128305A (zh) * | 2019-05-10 | 2019-08-16 | 天津大学 | 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途 |
| JP2021120357A (ja) * | 2020-01-30 | 2021-08-19 | サンノーバ株式会社 | 錠剤 |
| GB2599950A (en) * | 2020-10-16 | 2022-04-20 | Zentiva Ks | Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same |
| CN113143940A (zh) * | 2020-12-30 | 2021-07-23 | 成都恒瑞制药有限公司 | 一种抗糖尿病药物组合物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2347531A1 (de) * | 1973-09-21 | 1975-04-30 | Hoechst Ag | Arzneizubereitungen zur oralen diabetes-behandlung |
| IT1276130B1 (it) * | 1995-11-14 | 1997-10-27 | Gentili Ist Spa | Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo |
| BR9908911A (pt) * | 1998-03-19 | 2001-10-02 | Bristol Myers Squibb Co | Sistema bifásico e processo de distribuição por liberação controlada de substâncias farmacêuticas de alta solubilidade |
| PT974356E (pt) * | 1998-07-15 | 2004-02-27 | Merck Sante Sas | Comprimidos compreendendo uma combinacao de metformina e de glibenclamida |
| US6780432B1 (en) * | 2000-05-01 | 2004-08-24 | Aeropharm Technology, Inc. | Core formulation |
| US7964216B2 (en) * | 2001-01-12 | 2011-06-21 | Sun Pharma Advanced Research Company Limited | Spaced drug delivery system |
-
2001
- 2001-11-29 IT IT2001FI000230A patent/ITFI20010230A1/it unknown
-
2002
- 2002-11-22 AR ARP020104498A patent/AR037407A1/es unknown
- 2002-11-25 MY MYPI20024393A patent/MY141243A/en unknown
- 2002-11-26 UY UY27549A patent/UY27549A1/es not_active Application Discontinuation
- 2002-11-26 PE PE2002001140A patent/PE20030580A1/es not_active Application Discontinuation
- 2002-11-27 EG EG2002111281A patent/EG24124A/xx active
- 2002-11-28 SV SV2002001415A patent/SV2004001415A/es not_active Application Discontinuation
- 2002-11-29 MX MXPA04004974A patent/MXPA04004974A/es active IP Right Grant
- 2002-11-29 ES ES02791739T patent/ES2302862T3/es not_active Expired - Lifetime
- 2002-11-29 AU AU2002358061A patent/AU2002358061B2/en not_active Ceased
- 2002-11-29 EA EA200400664A patent/EA006766B1/ru not_active IP Right Cessation
- 2002-11-29 HU HU0402154A patent/HUP0402154A3/hu unknown
- 2002-11-29 PT PT02791739T patent/PT1458364E/pt unknown
- 2002-11-29 IL IL16214302A patent/IL162143A0/xx not_active IP Right Cessation
- 2002-11-29 CA CA002466677A patent/CA2466677A1/en not_active Abandoned
- 2002-11-29 PA PA20028559801A patent/PA8559801A1/es unknown
- 2002-11-29 PL PL369851A patent/PL206016B1/pl not_active IP Right Cessation
- 2002-11-29 CN CN028236920A patent/CN1596103B/zh not_active Expired - Fee Related
- 2002-11-29 SI SI200230693T patent/SI1458364T1/sl unknown
- 2002-11-29 KR KR10-2004-7006874A patent/KR20040079898A/ko not_active Application Discontinuation
- 2002-11-29 WO PCT/EP2002/013497 patent/WO2003045355A1/en active IP Right Grant
- 2002-11-29 EP EP02791739A patent/EP1458364B1/en not_active Expired - Lifetime
- 2002-11-29 HN HN2002000341A patent/HN2002000341A/es unknown
- 2002-11-29 BR BR0214403-4A patent/BR0214403A/pt not_active IP Right Cessation
- 2002-11-29 AT AT02791739T patent/ATE387190T1/de not_active IP Right Cessation
- 2002-11-29 UA UA20040504085A patent/UA81615C2/ru unknown
- 2002-11-29 DE DE60225331T patent/DE60225331T2/de not_active Expired - Lifetime
- 2002-11-29 JP JP2003546858A patent/JP4474162B2/ja not_active Expired - Lifetime
- 2002-11-29 NZ NZ533779A patent/NZ533779A/en not_active IP Right Cessation
- 2002-11-29 US US10/497,022 patent/US20050053661A1/en not_active Abandoned
- 2002-11-29 DK DK02791739T patent/DK1458364T3/da active
-
2004
- 2004-05-24 MA MA27696A patent/MA27087A1/fr unknown
- 2004-05-28 RS YUP-473/04A patent/RS50937B/sr unknown
- 2004-05-28 TN TNP2004000095A patent/TNSN04095A1/en unknown
- 2004-06-04 HR HRP20040501 patent/HRP20040501A2/hr not_active Application Discontinuation
- 2004-06-21 ZA ZA200404880A patent/ZA200404880B/en unknown
- 2004-06-28 NO NO20042713A patent/NO20042713L/no not_active Application Discontinuation
- 2004-06-29 CO CO04061363A patent/CO5590906A2/es not_active Application Discontinuation
-
2005
- 2005-03-18 HK HK05102373A patent/HK1069974A1/xx not_active IP Right Cessation
-
2008
- 2008-05-26 CY CY20081100543T patent/CY1107966T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030580A1 (es) | Composiciones farmaceuticas de glibenclamida y metformina, en capas separadas | |
| AR026560A1 (es) | Recubrimiento | |
| AR063959A1 (es) | Formulaciones farmaceuticas en capas | |
| AR055631A1 (es) | Composicion farmaceutica estable de glimepirida con liberacion inmediata y metformina con liberacion prolongada | |
| ES2176209T3 (es) | Preparacion farmaceutica oral liberable en el tracto digestivo inferior. | |
| AR037256A1 (es) | Forma de dosificacion de liberacion controlada dual | |
| PE20060375A1 (es) | Formas farmaceuticas orales, protegidas frente al abuso | |
| ES2037908T3 (es) | Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida. | |
| AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
| ES2101164T5 (es) | Composiciones farmaceuticas orales para el suministro especifico al colon. | |
| BR0106912A (pt) | Partìculas contendo ingrediente ativo | |
| AR013052A1 (es) | Una forma de dosis oral solida que comprende una combinacion de metformin y glibenclamida | |
| ECSP055733A (es) | Tabletas dispersables de deferacirox | |
| GT200000222A (es) | Forma de dosificacion de farmacos accionada por un hidrogel. | |
| HUP0201788A2 (en) | Multilayered film containing an active substance and made of cross-linked hydrophilic polymers | |
| BR0012869A (pt) | Forma de dosagem farmacêutica de componentes múltiplos | |
| PE20020307A1 (es) | Forma de dosificacion de farmaco activada por hidrogel | |
| UY26439A1 (es) | Nueva composición y uso | |
| AR054806A1 (es) | Formulaciones de estrogenos conjugados y bazedoxifeno | |
| AR026968A1 (es) | Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral | |
| WO2005025549A3 (en) | Multi-layer transdermal drug delivery device | |
| ES2148470T3 (es) | Farmaco analgesico antipiretico combinado. | |
| DE50200857D1 (de) | Primärverpackungseinheit für mehrere vereinzelte filmplättchen als darreichungsformen | |
| AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
| AR087240A2 (es) | Composiciones farmaceuticas que tienen epinastina y pseudoefedrina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |